Ad is loading...
MGFZX
Price
$10.92
Change
-$0.24 (-2.15%)
Updated
Nov 15 closing price
RNPHX
Price
$64.00
Change
-$0.92 (-1.42%)
Updated
Nov 15 closing price
Ad is loading...

MGFZX vs RNPHX

Header iconMGFZX vs RNPHX Comparison
Open Charts MGFZX vs RNPHXBanner chart's image
MassMutual Global I
Price$10.92
Change-$0.24 (-2.15%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R5E
Price$64.00
Change-$0.92 (-1.42%)
VolumeN/A
CapitalizationN/A
MGFZX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGFZX vs. RNPHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGFZX is a Buy and RNPHX is a StrongSell.

FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 142B vs. MGFZX (174M). RNPHX pays higher dividends than MGFZX: RNPHX (1.00) vs MGFZX (0.00). MGFZX was incepted earlier than RNPHX: MGFZX (11 years) vs RNPHX (9 years). RNPHX is a more actively managed with annual turnover of: 17.00 vs. MGFZX (10.00). MGFZX has a lower initial minimum investment than RNPHX: MGFZX (0) vs RNPHX (250). RNPHX annual gain was more profitable for investors over the last year : 18.29 vs. MGFZX (-7.54). RNPHX return over 5 years is better than : 39.74 vs. MGFZX (-18.55).
MGFZXRNPHXMGFZX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years9 years-
Gain YTD12.46115.64980%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets174M142B0%
Annual Yield % from dividends0.001.00-
Returns for 1 year-7.5418.29-41%
Returns for 3 years-45.59-9.77467%
Returns for 5 years-18.5539.74-47%
Returns for 10 years-24.14N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRNQ0.960.03
+3.23%
Greenpro Capital Corp
NDSN254.78-1.78
-0.69%
Nordson Corp
EHTH4.78-0.04
-0.83%
eHealth
PTCT39.23-3.15
-7.43%
PTC Therapeutics
SLN12.70-1.28
-9.16%
Silence Therapeutics Plc